1,956
Views
14
CrossRef citations to date
0
Altmetric
Review Article

The role of microRNAs in equine medicine: a review

, &
Pages 88-96 | Received 09 Feb 2015, Accepted 16 Feb 2015, Published online: 24 Mar 2015

References

  • Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, Dreyfuss G, Eddy SR, Griffiths-Jones S, Marshall M, et al. 2003. A uniform system for microRNA annotation. RNA. 9:277–279.
  • Anthon C, Tafer H, Havgaard JH, Thomsen B, Hedegaard J, Seemann SE, Pundhir S, Kehr S, Bartschat S, Nielsen M, et al. 2014. Structured RNAs and synteny regions in the pig genome. BMC Genomics. 15:459.
  • Barrey E, Bonnamy B, Barrey EJ, Mata X, Chaffaux S, Guerin G. 2010. Muscular microRNA expressions in healthy and myopathic horses suffering from polysaccharide storage myopathy or recurrent exertional rhabdomyolysis. Equine Vet J Suppl. 303–310.
  • Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell. 136:215–233.
  • Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297.
  • Berezikov E, Chung WJ, Willis J, Cuppen E, Lai EC. 2007. Mammalian mirtron genes. Mol Cell. 28:328–336.
  • Bhatt K, Mi QS, Dong Z. 2011. microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol. 300:F602–F610.
  • Bronze-da-Rocha E. 2014. MicroRNAs expression profiles in cardiovascular diseases. Biomed Res Int. doi:10.1155/2014/985408.
  • Buechli ME, Lamarre J, Koch TG. 2013. MicroRNA-140 expression during chondrogenic differentiation of equine cord blood-derived mesenchymal stromal cells. Stem Cells Dev. 22:1288–1296.
  • Buza T, Arick M 2nd, Wang H, Peterson DG. 2014. Computational prediction of disease microRNAs in domestic animals. BMC Res Notes. 7:403.
  • Caroli A, Cardillo MT, Galea R, Biasucci LM. 2013. Potential therapeutic role of microRNAs in ischemic heart disease. J Cardiol. 61:315–320.
  • Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al. 2008. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.
  • Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW, Lo YM. 2008. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem. 54(3):482–490.
  • Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. 2011. MicroRNAs in body fluids–the mix of hormones and biomarkers. Nat Rev Clin Oncol. 8:467–477.
  • Cullen BR. 2004. Derivation and function of small interfering RNAs and microRNAs. Virus Res. 102:3–9.
  • Desjardin C, Vaiman A, Mata X, Legendre R, Laubier J, Kennedy SP, Laloe D, Barrey E, Jacques C, Cribiu EP, Schibler L. 2014. Next-generation sequencing identifies equine cartilage and subchondral bone miRNAs and suggests their involvement in osteochondrosis physiopathology. BMC Genomics. 15:798.
  • Donadeu FX, Schauer SN. 2013. Differential miRNA expression between equine ovulatory and anovulatory follicles. Domest Anim Endocrinol. 45:122–125.
  • Eissa NT. 2013. The exosome in lung diseases: message in a bottle. J Allergy Clin Immunol. 131:904–905.
  • El-Hefnawy T, Raja S, Kelly L, Bigbee WL, Kirkwood JM, Luketich JD, Godfrey TE. 2004. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem. 50:564–573.
  • Erdmann VA, Barciszewska MZ, Hochberg A, de Groot N, Barciszewski J. 2001. Regulatory RNAs. Cell Mol Life Sci. 58:960–977.
  • Eulalio A, Huntzinger E, Izaurralde E. 2008. Getting to the root of miRNA-mediated gene silencing. Cell. 132:9–14.
  • Fasanaro P, Greco S, Ivan M, Capogrossi MC, Martelli F. 2010. microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther. 125:92–104.
  • Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS. 2005. Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol. 15:331–341.
  • Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, et al. 2014. Ensembl 2014. Nucleic Acids Res. 42:D749–D755.
  • Frankel LB, Di Malta C, Wen J, Eskelinen EL, Ballabio A, Lund AH. 2014. A non-conserved miRNA regulates lysosomal function and impacts on a human lysosomal storage disorder. Nat Commun. 5:5840.
  • Galasso M, Sana ME, Volinia S. 2010. Non-coding RNAs: a key to future personalized molecular therapy? Genome Med. 2:12.
  • Gamazon ER, Ziliak D, Im HK, LaCroix B, Park DS, Cox NJ, Huang RS. 2012. Genetic architecture of microRNA expression: implications for the transcriptome and complex traits. Am J Hum Genet. 90:1046–1063.
  • Gim JA, Ayarpadikannan S, Eo J, Kwon YJ, Choi Y, Lee HK, Park KD, Yang YM, Cho BW, Kim HS. 2014. Transcriptional expression changes of glucose metabolism genes after exercise in thoroughbred horses. Gene. 547:152–158.
  • Gitlin L, Stone JK, Andino R. 2005. Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J Virol. 79:1027–1035.
  • Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. 2006. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34:D140–D144.
  • Guo L, Zhao Y, Yang S, Zhang H, Wu Q, Chen F. 2014. An integrated evolutionary analysis of miRNA-lncRNA in mammals. Mol Biol Rep. 41:201–207.
  • Haj-Salem I, Fakhfakh R, Bérubé JC, Jacques E, Plante S, Simard MJ, Bossé Y, Chakir J. 2015. MicroRNA-19a enhances proliferation of bronchial epithelial cells by targeting TGFβR2 gene in severe asthma. Allergy. 70:212–219.
  • Huang XA, Lin H. 2012. The miRNA Regulation of Stem Cells. Wiley Interdiscip Rev Membr Transp Signal. 1:83–95.
  • Jevsinek Skok D, Godnic I, Zorc M, Horvat S, Dovc P, Kovac M, Kunej T. 2013. Genome-wide in silico screening for microRNA genetic variability in livestock species. Anim Genet. 44:669–677.
  • Kim MC, Lee SW, Ryu DY, Cui FJ, Bhak J, Kim Y. 2014. Identification and characterization of microRNAs in normal equine tissues by Next Generation Sequencing. PLoS One. 9:e93662.
  • Kim VN. 2005a. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385.
  • Kim VN. 2005b. Small RNAs: classification, biogenesis, and function. Mol Cells. 19:1–15.
  • Kirchner B, Paul V, Riedmaier I, Pfaffl MW. 2014. mRNA and microRNA purity and integrity: the key to success in expression profiling. Methods Mol Biol. 1160:43–53.
  • Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. 2005. Combinatorial microRNA target predictions. Nat Genet. 37:495–500.
  • Kunz M, Xiao K, Liang C, Viereck J, Pachel C, Frantz S, Thum T, Dandekar T. 2014. Bioinformatics of cardiovascular miRNA biology. J Mol Cell Cardiol. doi:10.1016/j.yjmcc.2014.11.027.
  • Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, et al. 2008. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 141:672–675.
  • Liang H, Gong F, Zhang S, Zhang CY, Zen K, Chen X. 2014. The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids. Wiley Interdiscip Rev RNA. 5:285–300.
  • Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. 2009. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One. 4:e6229.
  • Lv Y, Qi R, Xu J, Di Z, Zheng H, Huo W, Zhang L, Chen H, Gao X. 2014. Profiling of serum and urinary MicroRNAs in children with atopic dermatitis. PLoS One. 9:e115448.
  • Maegdefessel L. 2014. The emerging role of microRNAs in cardiovascular disease. J Intern Med. 276:633–44.
  • Mata X, Vaiman A, Ducasse A, Diribarne M, Schibler L, Guérin G. 2012. Genomic structure, polymorphism and expression of the horse alpha-actinin-3 gene. Gene. 491:20–24.
  • Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD. 2005. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell. 123:607–620.
  • Mattes J, Collison A, Plank M, Phipps S, Foster PS. 2009. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A. 106:18704–18709.
  • Mattick JS, Makunin IV. 2006. Non-coding RNA. Review. Hum Mol Genet. 15(1):R17–R29.
  • Meyer SU, Stoecker K, Sass S, Theis FJ, Pfaffl MW. 2014. Posttranscriptional regulatory networks: from expression profiling to integrative analysis of mRNA and microRNA data. Methods Mol Biol. 1160:165–188.
  • Nguyen TT, Brenu EW, Staines DR, Marshall-Gradisnik SM. 2014. MicroRNAs in the Intracellular Space, Regulation of Organelle Specific Pathways in Health and Disease. Microrna. 3(2):98–107.
  • Oliveira-Carvalho V, da Silva MM, Guimarães GV, Bacal F, Bocchi EA. 2013. MicroRNAs: new players in heart failure. Mol Biol Rep. 40:2663–2670.
  • Panganiban RPL, Pinkerton MH, Maru SY, Jefferson SJ, Roff AN, Ishmael FT. 2012. Differential microRNA epression in asthma and the role of miR-1248 in regulation of IL-5. Am J Clin Exp Immunol. 1:154–165.
  • Patnaik SK, Mallick R, Yendamuri S. 2010. Detection of microRNAs in dried serum blots. Anal Biochem. 407:147–149.
  • Peltier HJ, Latham GJ. 2008. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 14:844–852.
  • Price NL, Ramírez CM, Fernández-Hernando C. 2014. Relevance of microRNA in metabolic diseases. Crit Rev Clin Lab Sci. 51:305–320.
  • Rand TA, Petersen S, Du F, Wang X. 2005. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell. 123:621–629.
  • Robinson NE. 2001. International Workshop on Equine Chronic Airway Disease. Michigan State University 16-18 June 2000. Equine Vet J. 33:5–19.
  • Saunders MA, Liang H, Li WH. 2007. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A. 104:3300–3305.
  • Sayed D, Abdellatif M. 2011. MicroRNAs in development and disease. Physiol Rev. 91:827–887.
  • Schauer SN, Sontakke SD, Watson ED, Esteves CL, Donadeu FX. 2013. Involvement of miRNAs in equine follicle development. Reproduction. 146:273–282.
  • Schrimpf R, Dierks C, Martinsson G, Sieme H, Distl O. 2014. Genome-wide association study identifies phospholipase C zeta 1 (PLCz1) as a stallion fertility locus in Hanoverian warmblood horses. PLoS One. 9:e109675.
  • Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T. 2006. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 7:3.
  • Sethi S, Ali S, Kong D, Philip PA, Sarkar FH. 2013. Clinical implication of microRNAs in molecular pathology. Clin Lab Med. 33:773–786.
  • Silveira JC da, Veeramachaneni DN, Winger QA, Carnevale EM, Bouma GJ. 2012. Cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: a possible new form of cell communication within the ovarian follicle. Biol Reprod. 86:71.
  • Simpson LJ, Patel S, Bhakta NR, Choy DF, Brightbill HD, Ren X, Wang Y, Pua HH, Baumjohann D, Montoya MM, et al. 2014. A microRNA upregulated in asthma airway T cells promotes TH2 cytokine production. Nat Immunol. 15:1162–1170.
  • Smalheiser NR. 2007. Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol Direct. 2:35.
  • Song G, Wang L. 2009. A conserved gene structure and expression regulation of miR-433 and miR-127 in mammals. PLoS One. 4:e7829.
  • Sontheimer EJ, Carthew RW. 2005. Silence from within: endogenous siRNAs and miRNAs. Cell. 122:9–12.
  • Szymański M, Barciszewska MZ, Zywicki M, Barciszewski J. 2003. Noncoding RNA transcripts. J Appl Genet. 44:1–19.
  • Tan Z, Zhang W, Shi Y, Wang F. 2015. RNA folding: structure prediction, folding kinetics and ion electrostatics. Adv Exp Med Biol. 827:143–183.
  • Tay HL, Plank M, Collison A, Mattes J, Kumar RK, Foster PS. 2014. MicroRNA: potential biomarkers and therapeutic targets for allergic asthma? Ann Med. 46:633–639.
  • Théry C, Zitvogel L, Amigorena S. 2002. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2:569–579.
  • Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 9:654–659.
  • Wang K, Zhang S, Weber J, Baxter D, Galas DJ. 2010. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38:7248–7259.
  • Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. 2010. The microRNA spectrum in 12 body fluids. Clin Chem. 56:1733–1741.
  • Weiland M, Gao XH, Zhou L, Mi QS. 2012. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol. 9:850–859.
  • Weiler J, Hunziker J, Hall J. 2006. Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther. 13:496–502.
  • Winter J, Jung S, Keller S, Gregory RI, Diederichs S. 2009. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 11:228–234.
  • Yin J, Hou P, Wu Z, Wang T, Nie Y. 2015. Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma. Tumour Biol. [Epub ahead of print].
  • Zhang C. 2008. MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics. 33:139–147.
  • Zhao Q, Ping LI, Junrong MA, Xijie YU. 2015. MicroRNAs in lung cancer and lung cancer bone metastases: biomarkers for early diagnosis and targets for treatment. Recent Pat Anticancer Drug Discov. [Epub ahead of print]
  • Zhou M, Wang Q, Sun J, Li X, Xu L, Yang H, Shi H, Ning S, Chen L, Li Y, et al. 2009. In silico detection and characteristics of novel microRNA genes in the Equus caballus genome using an integrated ab initio and comparative genomic approach. Genomics. 94:125–131.
  • Zhu W, Qin W, Atasoy U, Sauter ER. 2009. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes. 2:89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.